SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3749La Jolla Pharma to Sell 8.7 Million Shares at Discount Friday February 20, 8:11 mopgcw2/23/2004
3748the renovis S-1 is quite interesting to read -- 1 for 4.5 reverse split and all.mopgcw2/23/2004
3747are there like a gazillion people watching the stock and playing with it, or is scaram(o)uche2/20/2004
3746dunno.... seems like a value of $0 is assigned to flurbie. if the world of pscaram(o)uche2/20/2004
3745>> Get on with it MYGN << It's typical Avalon et al. hammering.scaram(o)uche2/20/2004
3744And possibly not much longer before the current window closes (except for those nigel bates2/20/2004
3743**brilliant** management of a company that burned into the ground while liquiditscaram(o)uche2/20/2004
3742Thanks, George. to All....... if you're poking around an S-1, please scaram(o)uche2/20/2004
3741La Jolla Pharmaceutical Company Announces Common Stock Offering SAN DIEGO, Feb.nigel bates2/20/2004
3740Rigel Announces Offering of 3,165,000 Shares of Common Stock SOUTH SAN FRANCISCnigel bates2/20/2004
3739INSM competitor: Tercica IPO to offer 5.5 mln shares, $11-$13 each Reuters, 02.mopgcw2/20/2004
3738once again, new 52 week high notices are rolling in for a WIDE variety of biotecscaram(o)uche2/18/2004
3737Acceleron Pharma, Developing Drugs to Treat Musculoskeletal and Metabolic Disordnigel bates2/17/2004
3736This is only from the 1st two weeks of Feb. Wild. Still trying to figure out wmopgcw2/12/2004
3735yeah, makes no sense, but it also brings debt right under nose for a fresh look.scaram(o)uche2/12/2004
3734I've noticed that a lot of companies that issued converts during bubble timetuck2/12/2004
3733ERBITUX -Cetuximab- Receives FDA Approval to Treat Irinotecan Refractory or Intoscaram(o)uche2/12/2004
3732<i> I don't remember ever being a shareholder, but I was pulling for tnigel bates2/12/2004
3731BBIOY broke my heart. I don't remember ever being a shareholder, but I was scaram(o)uche2/12/2004
3730Oh, I see. Different subject.... back 10 years ago, when John and I met.... scaram(o)uche2/12/2004
3729No. 9 on the list - Message 19797448 (Currnetly part of something else, and a LOnigel bates2/12/2004
3728You lost me. (eom)scaram(o)uche2/12/2004
3727And BBIOY was there, just as a cautionary example ?nigel bates2/12/2004
3726Thanks for backing up the "supply dangerously high" thought, with justscaram(o)uche2/12/2004
3725oh, yeah, I forgot.... a rush on the back of one molecule, where the chemistscaram(o)uche2/12/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News